Cargando…

Epidermal Growth Factor Receptor: A Novel Target for Anticancer Treatment

Detalles Bibliográficos
Autores principales:	Pandey, Manoj, Chandramohan, K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194863/ https://www.ncbi.nlm.nih.gov/pubmed/12848894 http://dx.doi.org/10.1186/1477-7819-1-9

Ejemplares similares

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Src and Epidermal Growth Factor Receptor: Novel Partners in Mediating Chronic Hypoxia–induced Pulmonary Artery Hypertension
por: Gao, Yuansheng, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor: Is It a Feasible Target for the Treatment of Osteosarcoma?
por: Lee, Jun Ah, et al.
Publicado: (2012)

Picking the Right Patient for Human Epidermal Growth Factor Receptor 3–Targeted Therapy in Platinum-Resistant Ovarian Cancer
por: Schram, Alison M., et al.
Publicado: (2016)

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009)

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)

Nuclear epidermal growth factor receptor as a therapeutic target
por: Atwell, Benjamin, et al.
Publicado: (2023)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro
por: Han, Cui-yan, et al.
Publicado: (2013)

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab
por: Chikaishi, Yasuhiro, et al.
Publicado: (2020)

A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
por: Guo, Yuchen, et al.
Publicado: (2022)

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)
por: Höpfner, M, et al.
Publicado: (2003)

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
por: Kaufman, Nichole E. M., et al.
Publicado: (2021)

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab
por: Zhang, Liyi
Publicado: (2021)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2021)

The insulin-like growth factor system and its receptors: A potential novel anticancer target
por: Lindsay, Colin R, et al.
Publicado: (2008)

Phytochemicals targeting epidermal growth factor receptor (EGFR) for the prevention and treatment of HNSCC: A review
por: Li, Shaling, et al.
Publicado: (2023)

Epidermal growth factor receptor in glioblastoma
por: Xu, Hongsheng, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor in Pancreatic Cancer
por: Oliveira-Cunha, Melissa, et al.
Publicado: (2011)

Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
por: Tanaka, Yuka, et al.
Publicado: (2023)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
por: Wykosky, Jill, et al.
Publicado: (2011)

In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles
por: Baldi, Giovanni, et al.
Publicado: (2014)

Fibrogenic Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor: Myeloid or Epithelial Origin?
por: Martin, James G., et al.
Publicado: (2022)

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer
por: De Pasquale, Maria Debora, et al.
Publicado: (2020)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
por: Paranthaman, Sathishbabu, et al.
Publicado: (2020)

Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review
por: Merla, Amartej, et al.
Publicado: (2012)

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
por: Siddiqui, Mohammad R., et al.
Publicado: (2019)

Epidermal growth factor as a reliable marker of necrotizing enterocolitis in preterm neonates
por: Lee, Na Mi
Publicado: (2020)

Inhibiting Epidermal Growth Factor Receptor at a Distance
por: Sinclair, Julie K.-L., et al.
Publicado: (2014)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
por: Fischer, Alexandra, et al.
Publicado: (2020)

Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation
por: Brown, Wells S, et al.
Publicado: (2014)

Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin
por: Liu, Chia Wen, et al.
Publicado: (2012)

The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
por: Avila, Jorge, et al.
Publicado: (2023)

Novel Anticancer Strategies
por: Bousbaa, Hassan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c492m8vc93cpl1fv2tk4h1h2iu